Anhui Biochem United Pharmaceutical Co., Ltd.

Company Profile

Product Certification&
Enterprise Certification

Country: China (Mainland)

Business Type: Manufacturers

Mr.Biochem
Tel: 0086 551 5167062 / 5228268

Mobile:
Tel:0086 551 5167062 / 5228268
Fax:0086 551 5171062
Province/state:Anhui
City:Hefei
Street:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
MaxCard:

About us

Welcome To Our Site!
Anhui Biochem United Pharmaceutical Co., LTD (ABUP) is a professional high-tech company engaged in development, production, and marketing of chiral antivirals. The company, formerly known as Anhui Biochem Pharmaceutical Co., LTD, was founded as a joint venture with the QVT Fund in 2007. Its two subsidiaries are Anhui Biochem Bio-Pharmaceutical Co., LTD and Anhui Biochem Medical Sales Co., LTD.

ABUP has more than 600 employees whom 20% of them as research staff. Currently, the company has total assets of RMB600 million and covers 50.74 acres (205,333 square meters). It has a complete industrial chain running from API research, synthesis to FPP production and marketing. Meanwhile, ABUP has also undertaken the construction and research project of the Anhui Chiral Drugs Research Center, providing strong support for the enterprise’s development.

ABUP，mastered the core technology of world-leading chiral drugs， has the largest production and the most complete variety of anti-HBV and anti-HIV/AIDS API manufacturing bases in China. The company creates the precedent of domestic production of anti-HBV and anti-HIV and ends the history of dependence on imported antivirals.

ABUP will finally achieve the vision of "Respect life; Stop HBV &HIV/AIDS" by tightly grasping the historic opportunities of development, adhering to the objectives of the company, and sticking to the mission of the company.
Process Capability : Anhui Biochem United Pharmaceutical Co., LTD (ABUP), mastering the core technology of world-leading chiral drugs, has the largest production and the most complete variety of anti-HBV and anti-HIV/AIDS API manufacturing bases in China. The company creates the precedent of domestic production of anti-HBV and anti-HIV and ends the history of dependence on imported antivirals.